HIGHLIGHTS
- who: February et al. from the Cardiff University, United Kingdom have published the article: Tailoring therapies to counter the divergent immune landscapes of breast cancer, in the Journal: (JOURNAL)
- what: In this review, the authors aim to emphasize how the immune microenvironment may be used for clinical classifications of tumors and how the TIME regulates breast cancer growth, dissemination, and metastasis. The authors focused exclusively on discoveries made in the context of breast cancer as they represent a unique tumor model arising in mainly females and thus are responsive to estrogens. While the authors described . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.